House Democrats this week fired a shot across the bow of the nation's pharmaceutical companies as they begin a long-anticipated effort to cut down on high drug prices.
House Democrats this week fired a shot across the bow of the nation's pharmaceutical companies as they begin a long-anticipated effort to cut down on high drug prices.